Internet Ads

Published on June 27th, 2013


Meizi Evolution

The FDA is advising consumers to avoid “Meizi Evolution,” a product sold for weight-loss that was found to contain a hidden drug ingredient. According to the FDA,

FDA laboratory analysis confirmed that “Meizi Evolution” contains sibutramine.

Sibutramine can substantially increase blood pressure and pulse rate, and can present a danger to patients with heart or circulation issues. The FDA removed sibutramine from the market in 2010.

For more on weight-loss supplements, click here.

Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑